AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Cardlytics, Inc.
Video analysis: CDLX
All videosNo video analysis for this stock yet. Request one from our team.
News: CDLX
Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript
Cardlytics, Inc. (CDLX) Q2 2026 Earnings Call Transcript
Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX), a purchase intelligence platform, today announced financial results for the second quarter ended June 30, 2026. "The second quarter shows that our execution is translating directly into results. We were within our guidance across all key metrics, with margins improving every single month of the quarter,” said Amit Gupta, CEO of Cardlytics. “We added new advertiser relationships and deepened our partnerships with existing financial insti.
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) announced that on Aug. 3, 2026, Cardlytics granted an aggregate of 50,000 restricted stock units of Cardlytics to its newly appointed Chief Legal Officer, Chris Cheng. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). The restricted stock units shall v.
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on July 29, 2026, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 10,320 restricted stock units of Cardlytics to 10 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”). For a.
Cardlytics Appoints Chris Cheng as Chief Legal Officer
ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the appointment of Chris Cheng as Chief Legal Officer, effective August 3, 2026. Cheng will serve on the Leadership Team and oversee Cardlytics Legal and Compliance organization. Cheng brings more than 20 years of legal leadership experience at high-growth technology companies, with deep expertise supporting public companies and partnering with executive teams during periods of transformation. With senior legal experience.
Cardlytics to Report Second Quarter 2026 Results on August 5
[url="]Cardlytics, Inc.[/url] (NASDAQ: CDLX) today announced that its financial results for the second quarter ending June 30, 2026 will be released on August
Cardlytics to Report Second Quarter 2026 Results on August 5
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the second quarter ending June 30, 2026 will be released on August 5, 2026, after market close. Conference Call Details: When: August 5, 2026 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the.
